SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-23-002113
Filing Date
2023-03-17
Accepted
2023-03-17 16:15:58
Documents
57
Period of Report
2023-01-31

Document Format Files

Seq Description Document Type Size
1 10-Q organicellregen_10q.htm   iXBRL 10-Q 621483
2 EXHIBIT 31.1 organicellregen_ex31-1.htm EX-31.1 17778
3 EXHIBIT 32.1 organicellregen_ex32-1.htm EX-32.1 5588
  Complete submission text file 0001829126-23-002113.txt   3746626

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bpsr-20230131.xsd EX-101.SCH 37059
5 XBRL CALCULATION FILE bpsr-20230131_cal.xml EX-101.CAL 47504
6 XBRL DEFINITION FILE bpsr-20230131_def.xml EX-101.DEF 122163
7 XBRL LABEL FILE bpsr-20230131_lab.xml EX-101.LAB 263827
8 XBRL PRESENTATION FILE bpsr-20230131_pre.xml EX-101.PRE 210286
51 EXTRACTED XBRL INSTANCE DOCUMENT organicellregen_10q_htm.xml XML 487446
Mailing Address 1951 NW 7TH AVENUE SUITE 300 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 300 MIAMI FL 33136 888-963-7881
Organicell Regenerative Medicine, Inc. (Filer) CIK: 0001557376 (see all company filings)

IRS No.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 000-55008 | Film No.: 23742781
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences